Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 09:12 am Sale | 2024-12-31 | 13G | Innoviva, Inc. INVA | Westfield Capital Management Company, L.P. | 0 0.000% | -4,106,136 (Position Closed) | Filing History |
| 2025-01-27 1:04 pm Sale | 2024-12-31 | 13G | Innoviva, Inc. INVA | FRANKLIN RESOURCES INC BEN | 4,432,301 7.100% | -1,980,399 (-30.88%) | Filing History |
| 2024-11-14 4:17 pm Unchanged | 2024-11-12 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.200% | 0 (Unchanged) | Filing History |
| 2024-05-13 1:58 pm Unchanged | 2024-04-30 | 13G | Innoviva, Inc. INVA | FRANKLIN RESOURCES INC BEN | 6,412,700 10.200% | 0 (Unchanged) | Filing History |
| 2024-05-08 3:38 pm Purchase | 2024-04-30 | 13D | Innoviva, Inc. INVA | FRANKLIN RESOURCES INC BEN | 6,412,700 10.200% | 6,412,700 (New Position) | Filing History |
| 2024-03-04 5:35 pm Unchanged | 2024-03-04 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | Filing History |
| 2024-02-14 07:23 am Purchase | 2023-12-31 | 13G | Innoviva, Inc. INVA | PUTNAM INVESTMENTS LLC | 6,270,413 9.800% | 941,306 (+17.66%) | Filing History |
| 2024-02-13 5:06 pm Sale | 2023-12-29 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 6,712,443 10.470% | -359,769 (-5.09%) | Filing History |
| 2024-02-13 10:26 am Sale | 2023-12-29 | 13G | Innoviva, Inc. INVA | RENAISSANCE TECHNOLOGIES LLC | 4,144,447 6.470% | -85,160 (-2.01%) | Filing History |
| 2024-02-09 09:59 am Purchase | 2024-02-14 | 13G | Innoviva, Inc. INVA | DIMENSIONAL FUND ADVISORS LP | 4,516,999 7.000% | 4,516,999 (New Position) | Filing History |
| 2024-01-22 2:03 pm Sale | 2023-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 10,349,116 16.100% | -262,723 (-2.48%) | Filing History |
| 2023-07-11 08:27 am Unchanged | 2023-07-10 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | Filing History |
| 2023-05-15 5:05 pm Purchase | 2023-05-11 | 13D | Innoviva, Inc. INVA | Sarissa Capital Management LP | 6,904,000 10.540% | 490,000 (+7.64%) | Filing History |
| 2023-02-14 1:05 pm Purchase | 2022-12-31 | 13G | Innoviva, Inc. INVA | PUTNAM INVESTMENTS LLC | 5,329,107 7.600% | 5,329,107 (New Position) | Filing History |
| 2023-02-13 10:27 am Sale | 2022-12-30 | 13G | Innoviva, Inc. INVA | RENAISSANCE TECHNOLOGIES LLC | 4,229,607 6.060% | -1,065,526 (-20.12%) | Filing History |
| 2023-02-10 2:11 pm Unchanged | 2022-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 10,611,839 15.200% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 7,072,212 10.130% | 101,262 (+1.45%) | Filing History |
| 2023-02-01 7:39 pm Purchase | 2022-12-30 | 13G | Innoviva, Inc. INVA | Westfield Capital Management Company, L.P. | 4,106,136 5.880% | 422,651 (+11.47%) | Filing History |
| 2023-01-26 08:52 am Purchase | 2022-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 10,611,839 10.600% | 4,940,739 (+87.12%) | Filing History |
| 2023-01-20 5:17 pm Sale | 2022-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 5,671,100 10.600% | -3,337,658 (-37.05%) | Filing History |